
Description:
CJC-1295 without DAC (also referred to as Modified GRF 1-29) is a synthetic analog of growth hormone releasing hormone (GHRH) studied for its role in pulsatile growth hormone secretion and hypothalamic-pituitary axis regulation. Without the Drug Affinity Complex, this variant maintains a shorter half-life allowing for more controlled GH pulse timing in research models. Preclinical research has explored its effects on GH release patterns, IGF-1 pathway activity, lean body composition, and metabolic regulation across controlled in-vitro and in-vivo research models.
The lyophilized preparation enables accurate laboratory reconstitution using sterile handling techniques. Consistent preparation methods and appropriate storage conditions help maintain compound stability and improve reproducibility during extended research cycles.
Product Specifications
For research purposes only. Not for human or animal use & not FDA-approved. By purchasing, you confirm you are 21 or older and a qualified researcher
